Precision medicine--personalized, problematic, and promising.

@article{Jameson2015PrecisionMP,
  title={Precision medicine--personalized, problematic, and promising.},
  author={J Larry Jameson and D. Longo},
  journal={The New England journal of medicine},
  year={2015},
  volume={372 23},
  pages={
          2229-34
        }
}
This article considers the growing recognition of precision medicine by clinicians, patients, the pharmaceutical industry, and policymakers and summarizes how this rapidly accelerating field will leave a major imprint on the practice of medicine. 
View on PubMed
blogs.lt.vt.edu
767 Citations
Highly Influential Citations
19
Background Citations
271
Methods Citations
34

Figures, Tables, and Topics from this paper

767 Citations

Citation Type

Citation Type

Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine
By integrating genetic, biomarker, phenotypic, and psychosocial characteristics that distinguish one patient from others with similar clinical presentations, the aim of precision medicine is to…
Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.
An IOM committee focused on biomarkers for molecularly targeted therapies has issued recommendations about regulatory, reimbursement, and clinical practice issues, in order to guide precision…
The Promising Prospects of Precision Medicine
TLDR
Since precision medicine will make the clinical guidelines much more conditional and branched, it is expected that physicians would increasingly require informatics and algorithms supports to assist them with information management and evidence-based decision-making in medical contexts.
A Look Forward - The Frontiers in Medicine Series.
This week we introduce Frontiers in Medicine, a series of review articles that showcases the ways in which new technologies are influencing contemporary medicine and highlights the synergistic rela...
Clinical Research and Evidence-Based Medicine
TLDR
This approach advocates the use of various levels of evidence regarding the source of medical data and classification of indications to offer guideline recommendations on how to treat patients.
Precision Medicine-The New Reality.
  • Jan Odom-Forren
  • Medicine
    Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses
  • 2015
Making individualized drugs a reality
Magistral drug preparation offers a model to circumvent many of the technological, regulatory and financial challenges that prevent provision of the right drug at the right time to the right patient.
The FDA and genomic tests--getting regulation right.
The authors review the nature of the proposal by the FDA for the regulation of next-generation sequencing and laboratory-developed tests in clinical medicine and offer thoughts on what is needed to…
Precision medicine with electronic medical records: from the patients and for the patients.
The ideas of incorporating individual variabilities for prevention and treatment of diseases are getting paramount importance nowadays in modern medicine, otherwise known as precision medicine.
How “precise” is precision medicine in hematology?
TLDR
Massive parallel sequencing allows us to sequence the entire exome (the coding sequences of the genome) of leukemia or lymphoma cells, and can be combined with RNA-Seq to evaluate the transcriptome.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Preparing for precision medicine.
Precision medicine uses clinicopathological indexes and molecular profiling to create diagnostic, prognostic, and therapeutic strategies tailored to the patient. Its success depends on establishing…
A new initiative on precision medicine.
TLDR
A research initiative that aims to accelerate progress toward a new era of precision medicine, with a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.
Cutting the Gordian helix--regulating genomic testing in the era of precision medicine.
  • E. Lander
  • Biology, Medicine
    The New England journal of medicine
  • 2015
The new Precision Medicine Initiative will require advances in our regulatory frameworks, especially for genomic testing. The FDA has been exploring radical new approaches, aiming to promote rapid…
The FDA and genomic tests--getting regulation right.
The authors review the nature of the proposal by the FDA for the regulation of next-generation sequencing and laboratory-developed tests in clinical medicine and offer thoughts on what is needed to…
Trastuzumab--mechanism of action and use in clinical practice.
  • C. Hudis
  • Biology, Medicine
    The New England journal of medicine
  • 2007
TLDR
Trastuzumab, a humanized monoclonal antibody that targets HER2, is approved by the Food and Drug Administration for patients with invasive breast cancers that overexpress HER2.
Gene-panel sequencing and the prediction of breast-cancer risk.
An international group of cancer geneticists review the level of evidence for the association of gene variants with the risk of breast cancer. It is difficult to draw firm conclusions from the data…
Acute HIV-1 Infection.
TLDR
This review addresses recent advances in the understanding of the transmission of HIV-1 and of acute HIV- 1 infection.
Tumor immunotherapy directed at PD-1.
  • A. Ribas
  • Biology, Medicine
    The New England journal of medicine
  • 2012
TLDR
These trials have led to a low frequency of durable tumor responses in selected cancers such as melanoma and renal-cell carcinoma at the expense of other types of cancer.
Precision medicine: the future or simply politics?
TLDR
Advances in data science, better computing power, and electronic medical records, not to mention the dramatic drop in the cost to sequence an individual’s entire genome, make 2015 “a perfect time to launch the Precision Medicine Initiative,” Collins said at a press conference before the president's speech.
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
TLDR
This paper reviews the development process of the CPIC guidelines and compares this process to the Institute of Medicine’s Standards for Developing Trustworthy Clinical Practice Guidelines.
...
1
2
3
4
...